Granite Investment Partners LLC lowered its position in shares of Exponent, Inc. (NASDAQ:EXPO - Free Report) by 9.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 41,895 shares of the business services provider's stock after selling 4,490 shares during the period. Granite Investment Partners LLC owned 0.08% of Exponent worth $3,733,000 as of its most recent filing with the Securities and Exchange Commission.
Other large investors have also recently added to or reduced their stakes in the company. Private Trust Co. NA increased its holdings in Exponent by 129.8% in the 4th quarter. Private Trust Co. NA now owns 278 shares of the business services provider's stock valued at $25,000 after buying an additional 157 shares during the period. Atala Financial Inc bought a new position in Exponent in the fourth quarter valued at about $25,000. Westside Investment Management Inc. bought a new position in shares of Exponent in the third quarter worth about $26,000. Tortoise Investment Management LLC lifted its stake in shares of Exponent by 76.7% in the 4th quarter. Tortoise Investment Management LLC now owns 440 shares of the business services provider's stock valued at $39,000 after acquiring an additional 191 shares during the last quarter. Finally, Trust Co. of Vermont acquired a new position in shares of Exponent in the fourth quarter valued at approximately $45,000. Institutional investors own 92.37% of the company's stock.
Insiders Place Their Bets
In related news, VP Richard Reiss sold 1,736 shares of the stock in a transaction on Wednesday, February 26th. The shares were sold at an average price of $85.93, for a total transaction of $149,174.48. Following the transaction, the vice president now directly owns 1,800 shares of the company's stock, valued at $154,674. This represents a 49.10 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 2.10% of the company's stock.
Exponent Stock Performance
Shares of EXPO traded down $1.11 during mid-day trading on Friday, reaching $78.28. 302,366 shares of the company were exchanged, compared to its average volume of 242,306. Exponent, Inc. has a 52 week low of $73.83 and a 52 week high of $115.75. The business has a 50 day simple moving average of $82.62 and a two-hundred day simple moving average of $92.46. The stock has a market capitalization of $3.98 billion, a PE ratio of 36.92 and a beta of 0.84.
Exponent (NASDAQ:EXPO - Get Free Report) last announced its quarterly earnings data on Thursday, February 6th. The business services provider reported $0.46 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.40 by $0.06. Exponent had a return on equity of 27.27% and a net margin of 19.52%. During the same period in the prior year, the business posted $0.41 EPS. On average, analysts predict that Exponent, Inc. will post 1.98 EPS for the current year.
Exponent Profile
(
Free Report)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
See Also

Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.